Clinical Trials Browser

INDUSTRY × Interventional × Peripheral Nervous System Diseases × Clear all

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT04865679 2025-05-02

REPOSE-XL℠

Nervous System Diseases, Neuralgia, Neuroma, Peripheral Nervous System Diseases, Trauma, Nervous System, Peripheral Nerve Injuries

NCT05488873 2024-07-22

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

Phase 2 Active not recruiting

60 enrolled

Neoplasms, Peripheral Nervous System Diseases

NCT04675450 2023-06-08

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Phase 2 Withdrawn

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04034355 2022-01-26

POLAR-A

Phase 3 Terminated

301 enrolled 18 charts

Gastrointestinal

Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase 2 Completed

150 enrolled

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

NCT00267007 2014-06-04

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Phase 2 Terminated

32 enrolled 9 charts

Neoplasms, Peripheral Nervous System Diseases

NCT00380965 2008-02-15

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

Phase 4 Completed

23 enrolled

Neoplasms, Peripheral Nervous System Diseases

NCT00041795 2005-06-24

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Phase 2 Completed

50 enrolled

Peripheral Nervous System Diseases

Clinical Trials

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

REPOSE-XL℠

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

POLAR-A

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy